表紙:MRIの世界市場の評価:磁場強度別、設計別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)
市場調査レポート
商品コード
1400702

MRIの世界市場の評価:磁場強度別、設計別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)

Magnetic Resonance Imaging Market Assessment, By Field Strength, By Design, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 228 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
MRIの世界市場の評価:磁場強度別、設計別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)
出版日: 2024年01月03日
発行: Market Xcel - Markets and Data
ページ情報: 英文 228 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のMRIの市場規模は、2023年に74億米ドル、2031年に115億1,000万米ドルに達し、2024年~2031年の予測期間にCAGRで5.68%の成長が見込まれています。市場は近年、重大な要因の重なりと顕著な技術革新に後押しされ、大幅な成長を示しています。市場拡大の主な要因は、老年人口の増加、慢性疾患の罹患率の増加、新技術の導入、新興国における設置の増加と意識の高まりです。

コンピューターサイエンス、データ処理、半導体などのさまざまな分野の新技術が、MRI技術の進歩に急速に不可欠なものとなっています。この統合は、革新的な用途の創造につながっています。HPCとMRI技術の進歩の相乗効果により、MRIは現在、機能的および解剖学的な画像データの広範なセットを生成することができ、これは複数の疾患にわたる重要なリソースとして役立っています。MRI装置の高いコストやMRI検査技師の不足といった要因が、市場にマイナスの影響を与えています。

老年人口の増加と慢性疾患の罹患率の増加

市場は、老年人口の増加と慢性疾患の罹患率の向上を主因として、大幅な成長を示しています。近年、老年人口が大幅に増加しており、診察や診断サービスを求める高齢者が増えています。高齢化に伴い、心血管疾患、がん、神経疾患などの慢性疾患を含むさまざまな健康問題への感受性が高まります。2030年までに、世界の6人に1人が60歳以上の高齢者となります。この期間、世界人口に占める60歳以上の高齢者の割合は、2020年の10億人から14億人に増加します。2050年に目を向けると、60歳以上の世界人口は倍増し、21億人に達すると予測されています。さらに、80歳以上の高齢者の数は2020年~2050年に3倍になり、4億2,600万人に達すると予測されています。MRI技術は、これらの疾患の早期発見、正確な診断、モニタリングに有用であることが証明されています。MRIは非侵襲で高解像度な画像診断が可能であるため、医療従事者に好まれています。MRIは、動脈瘤、眼/耳疾患、脳卒中、腫瘍、脳損傷、靭帯損傷などの疾患の発見に役立っています。その結果、医療提供者や患者が、患者の予後を改善し、より効率的な医療管理を支える技術の役割を認識するようになり、MRI技術に対する需要が急増しています。

新技術の導入

MRI技術の進歩により、市場における技術革新が加速しています。高磁場MRIスキャナー、マルチパラメトリックイメージング、AIを活用した画像解析などの新たな開発により、画質と診断精度が大幅に向上しました。さらに、機能的MRI(fMRI)と拡散テンソルイメージング(DTI)の統合は、脳機能と結合性の理解における新たな可能性を引き出し、神経疾患の診断と治療に役立っています。さらに、MRI装置の小型化とポータブルシステムの登場により、この診断ツールは遠隔地や十分なサービスを受けていない地域でも利用しやすくなっています。

高磁場強度MRIと超高磁場強度MRIが市場を独占

現在、高磁場強度MRIと超高磁場強度MRI技術が市場を独占しています。これらの先進のMRIシステムは高い画像解像度を提供し、より精密で詳細な診断を可能にします。一般的に1.5テスラまたは3テスラで動作する高磁場MRIは、さまざまな臨床用途の標準となっており、4テスラ以上で動作する超高磁場MRIは、研究や特殊な臨床現場で脚光を浴びています。これらの強力なMRIシステムは、ニューロイメージング、心血管の調査、神経疾患の研究に役立っており、以前は収集が困難だった貴重な知見を提供しています。高磁場強度での動作の主な利点は、S/N比の向上と化学シフトの強化です。高いS/N比は、診断の質を損なうことなくスキャン時間を短縮したり、空間分解能を高めたりするために利用できます。

新興国におけるMRI設置の増加と意識の高まり

MRI装置の設置は新興国で増加傾向にあり、医療インフラに大きな変化をもたらしています。この増加は、医療予算の増加、中間所得層の増加、早期の診断と治療における先進の医用画像の重要な役割の認識などの要因によるものと考えられます。さらに、さまざまな病状の検出やモニタリングにおけるMRIの利点について、医療従事者や市民の認識が高まっていることも、この拡大を後押ししています。MRIサービスが利用可能になることで、質の高い医療へのアクセスが向上し、より正確な診断と患者の転帰の改善が可能になります。この動向は、先進国と新興国の医療格差の解消に向けた前向きな一歩を反映しています。

当レポートでは、世界のMRI市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 世界のMRI市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 世界のMRI市場の見通し(2017年~2031年)

  • 市場規模と予測
    • 金額
    • 数量
  • 磁場強度
    • 超高
  • 設計
    • オープン型MRI
    • 従来型MRI
    • ワイドボアMRI
  • 用途
    • 心臓病
    • 腫瘍
    • 神経内科
    • 筋骨格
    • 整形外科
    • 消化器科
    • その他
  • エンドユーザー
    • 病院
    • 診断センター、画像センター
    • 外来手術センター
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ
  • 企業の市場シェア(2022年)

第6章 世界のMRI市場の見通し(2017年~2031年)

  • 北米
    • 磁場強度
    • 設計
    • 用途
    • エンドユーザー
  • カナダ
  • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 南米
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第7章 市場マッピング(2023年)

  • 磁場強度
  • 設計
  • 用途
  • エンドユーザー
  • 地域

第8章 マクロ環境と産業構造

  • 需給分析
  • 輸出入の分析 - 数量と金額
  • サプライ/バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第9章 市場力学

  • 成長促進要因
  • 成長抑制要因(課題、抑制要因)

第10章 規制の枠組みとイノベーション

  • 臨床試験
  • 特許情勢
  • 規制当局の承認
  • イノベーション/新技術

第11章 主要企業情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析(2023年)
  • 合併と買収/合弁事業(該当する場合)
  • SWOT分析(市場参入企業5社向け)
  • 特許分析(該当する場合)

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

  • GE Healthcare Technologies Inc.
  • Canon Medical Systems Corporation
  • Koninklijke Philips N.V
  • Siemens Healthineers AG
  • Hitachi Ltd
  • Aurora Imaging Technologies Inc.
  • Fujifilm Holdings Corporation
  • Neusoft Medical Systems Co. Ltd
  • Bruker Corporation
  • Fonar Corporation

第15章 戦略的推奨事項

第16章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 4. Global Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 5. Global Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Magnetic Resonance Imaging Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 10. North America Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 11. North America Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 12. North America Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Magnetic Resonance Imaging Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 17. United States Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 18. United States Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 19. United States Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 23. Canada Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 24. Canada Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 25. Canada Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 29. Mexico Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 30. Mexico Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 31. Mexico Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 35. Europe Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 36. Europe Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 37. Europe Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Magnetic Resonance Imaging Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 42. Germany Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 43. Germany Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 44. Germany Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. France Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 49. France Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 50. France Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 51. France Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 54. Italy Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 55. Italy Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 56. Italy Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 60. United Kingdom Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 61. United Kingdom Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 62. United Kingdom Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 66. Russia Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 67. Russia Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 68. Russia Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 72. Netherlands Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 73. Netherlands Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 74. Netherlands Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 78. Spain Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 79. Spain Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 80. Spain Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 84. Turkey Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 85. Turkey Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 86. Turkey Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Poland Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 91. Poland Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 92. Poland Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 96. South America Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 97. South America Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 98. South America Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Magnetic Resonance Imaging Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 103. Brazil Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 104. Brazil Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 105. Brazil Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 109. Argentina Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 110. Argentina Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 111. Argentina Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 115. Asia-Pacific Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 116. Asia-Pacific Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 117. Asia-Pacific Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Magnetic Resonance Imaging Market Share (%), By Country, 2017-2031F
  • Figure 120. India Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 122. India Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 123. India Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 124. India Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 125. India Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 128. China Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 129. China Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 130. China Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 131. China Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 134. Japan Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 135. Japan Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 136. Japan Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 140. Australia Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 141. Australia Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 142. Australia Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 146. Vietnam Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 147. Vietnam Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 148. Vietnam Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 152. South Korea Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 153. South Korea Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 154. South Korea Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 158. Indonesia Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 159. Indonesia Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 160. Indonesia Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 164. Philippines Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 165. Philippines Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 166. Philippines Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 170. Middle East & Africa Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 171. Middle East & Africa Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 172. Middle East & Africa Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Magnetic Resonance Imaging Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 177. Saudi Arabia Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 178. Saudi Arabia Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 179. Saudi Arabia Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. UAE Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 184. UAE Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 185. UAE Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Magnetic Resonance Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Magnetic Resonance Imaging Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 189. South Africa Magnetic Resonance Imaging Market Share (%), By Field Strength, 2017-2031F
  • Figure 190. South Africa Magnetic Resonance Imaging Market Share (%), By Design, 2017-2031F
  • Figure 191. South Africa Magnetic Resonance Imaging Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Magnetic Resonance Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Field Strength Map-Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Design Map-Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX10787

Global magnetic resonance imaging market size was valued at USD 7.4 billion in 2023, expected to reach USD 11.51 billion in 2031, with a CAGR of 5.68% for the forecast period between 2024 and 2031F. The global magnetic resonance imaging market has experienced substantial growth in recent years, driven by a convergence of key factors and fueled by remarkable innovations. Market expansion is primarily attributed to the growing geriatric population, increasing incidence of chronic diseases, introduction of novel technologies, and increasing installation and growing awareness in emerging countries.

Emerging technologies from different fields such as computer science, data processing, and semiconductors have quickly become integral to advancements in MRI technology. This integration has led to the creation of innovative applications. Through the synergies of high-performance computing and advancements in MRI technology, MRI can now generate extensive sets of both functional and anatomical image data, which serves as a vital resource across multiple diseases. Factors such as the high cost of MRI machines and the shortage of MRI technologists are negatively impacting the global magnetic resonance imaging (MRI) market.

Growing Geriatric Population and Increasing Incidence of Chronic Diseases

The global magnetic resonance imaging market is experiencing substantial growth, largely driven by the growing geriatric population and the rising incidence of chronic diseases. The aging demographic has considerably increased in recent years, with more elderly individuals seeking medical attention and diagnostic services. As individuals age, their susceptibility to various health issues, including chronic diseases such as cardiovascular conditions, cancer, and neurological disorders, increases. By the year 2030, one out of every six individuals worldwide will have reached the age of 60 or older. During this period, the proportion of global population comprising those aged 60 and above will rise from 1 billion in 2020 to 1.4 billion. Looking ahead to 2050, the global population of individuals aged 60 and older is projected to double, reaching 2.1 billion. Furthermore, the number of people aged 80 or older is anticipated to triple between 2020 and 2050, reaching 426 million. MRI technology has proven valuable in the early disease detection, accurate diagnosis, and monitoring of these conditions. It offers non-invasive, high-resolution imaging, making it a preferred choice for healthcare professionals. MRI aids in detecting conditions such as aneurysm, eye/ear disorders, stroke, tumor, brain injuries, and ligament injuries. Consequently, the demand for MRI technologies has surged as healthcare providers and patients recognize technology's role in improving patient outcomes and ensuring more efficient healthcare management.

Introduction of Novel Technologies

Advancements in MRI technologies have accelerated innovation in the global magnetic resonance imaging (MRI) market. Novel developments, such as higher-field MRI scanners, multi-parametric imaging, and AI-driven image analysis, have significantly improved image quality and diagnostic accuracy. Furthermore, the integration of functional MRI (fMRI) and diffusion tensor imaging (DTI) has unlocked new possibilities in understanding brain function and connectivity, aiding in the diagnosis and treatment of neurological conditions. Additionally, the miniaturization of MRI machines and the advent of portable systems have made this diagnostic tool more accessible, even in remote or underserved regions.

In September 2023, the FDA granted regulatory approval for IGAR, a robotics system created by Insight Medbotics, making it the first and only robotic platform specifically engineered to operate within the MRI bore. The pioneering technology, IGAR, has the potential for future adaptations to function in various hospital settings. Insight Medbotics has showcased the safety and effectiveness of IGAR through publicly available clinical studies focused on breast biopsy procedures.

At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 Annual Meeting, GE Healthcare introduced its SIGNA PET/MR AIR. During the event, the company presented the incorporation of its state-of-the-art AIR technologies into the SIGNA PET/MR AIR system, aiming to improve diagnostic accuracy, streamline treatment assessment, and enhance the overall comfort of patients.

High Field Strength MRI and Ultra High Field Strength MRI Are Dominating the Market

High field strength MRI and ultra-high field strength MRI technologies are currently dominating the MRI market. These advanced MRI systems offer high image resolution, allowing for more precise and detailed diagnosis. High field MRI, typically operating at 1.5 Tesla or 3 Tesla, has become the standard for various clinical applications, while ultra-high field MRI, operating beyond 4 Tesla or higher, is gaining prominence in research and specialized clinical settings. These powerful MRI systems are instrumental in neuroimaging, cardiovascular studies, and research into neurological disorders, providing invaluable insights that were previously difficult to gather. The primary benefits of operating at high field strengths include an increased signal-to-noise ratio and enhanced chemical shift. High signal-to-noise ratio can be used to either reduce scanning time without compromising diagnostic quality or to enhance spatial resolution.

In February 2023, A group of seven organizations, led by the Donders Institute of Brain, Cognition, and Behavior, has been awarded EUR 19 million roadmap grant from the Dutch Research Council. This funding will be dedicated to the development of the world's inaugural 14 Tesla MRI scanner. The heightened sensitivity of this scanner will enable researchers to achieve more comprehensive brain imaging, leading to an improved understanding of brain function. Additionally, it will provide fresh insights into disease mechanisms and their treatment across the entire human body.

Increasing Installation of MRI and Growing Awareness in Emerging Countries

The installation of MRI machines is on the rise in emerging countries, marking a significant shift in healthcare infrastructure. The increase can be attributed to several factors, including rising healthcare budgets, a growing middle-class population, and the recognition of the vital role that advanced medical imaging plays in early diagnosis and treatment. Additionally, the growing awareness among healthcare professionals and the public about the benefits of MRI in detecting and monitoring various medical conditions has driven this expansion. The availability of MRI services is improving access to high-quality healthcare, allowing for more accurate diagnosis and better patient outcomes. This trend reflects a positive step towards bridging the healthcare gap between developed and emerging nations.

Impact of COVID-19

The global magnetic resonance imaging (MRI) market experienced significant impacts due to the COVID-19 pandemic. Initially, as healthcare resources were diverted towards managing the pandemic, non-essential medical procedures, including elective MRI scans, were postponed or canceled to prioritize COVID-19 patients. It led to a temporary downturn in MRI utilization and revenue for many healthcare facilities. However, the pandemic highlighted the importance of advanced diagnostic imaging in healthcare. As COVID-19 cases surged, MRI played a crucial role in assessing the extent of lung damage and monitoring patients' conditions. Moreover, the awareness of the need for faster and more efficient MRI diagnosis for COVID-19-related complications led to innovations in MRI technology. In the post-COVID-19 era, there has been a notable surge in the utilization of AI and machine learning in MRI, revolutionizing the field of medical imaging. These technologies are enhancing diagnostic accuracy, automating image analysis, and expediting the interpretation of MRI scans.

Key Player Landscape and Outlook

The global magnetic resonance imaging market features a landscape dominated by key players such as GE Healthcare Technologies Inc., Canon Medical System Corporation, Koninklijke Philips N.V, Siemens Healthineers AG, Hitachi Ltd, Aurora Imaging Technologies Inc., Fujifilm Holdings Corporation, and others. Companies are enhancing their imaging capabilities by manufacturing MRI scanners that have ultra-high field strength by surpassing the old high field strength of 3 Tesla. Market players are designing MRI scanners that are open or have wide bore for patients that are claustrophobic. Market players are developing partnerships to reach emerging markets.

In September 2023, Siemens Healthineers announced the FDA approval of Magnetom Viato.Mobile, a novel 1.5 Tesla (1.5T) magnetic resonance (MR) imaging scanner. This MRI scanner is specially designed for mobile applications, offering increased versatility for deploying MR imaging. It can be conveniently set up on a trailer, facilitating transportation to remote locations, thus extending the accessibility of advanced medical imaging to patients, including those with significant health issues, who would otherwise face long journeys for such services.

In October 2023, Philips announced its collaboration with Quibim to introduce advanced AI-driven imaging software aimed at prostate cancer detection. By combining Philips' innovative AI-enhanced MR imaging software with Quibim's AI-powered image analysis software, healthcare providers can expedite and simplify prostate cancer diagnosis and care.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on Global Magnetic Resonance Imaging Market

4. Executive Summary

5. Global Magnetic Resonance Imaging Market Outlook, 2017-2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Field Strength
    • 5.2.1. Low
    • 5.2.2. Medium
    • 5.2.3. High
    • 5.2.4. Ultra-High
  • 5.3. Design
    • 5.3.1. Open MRI
    • 5.3.2. Traditional MRI
    • 5.3.3. Wide Bore MRI
  • 5.4. Application
    • 5.4.1. Cardiology
    • 5.4.2. Oncology
    • 5.4.3. Neurology
    • 5.4.4. Musculoskeletal
    • 5.4.5. Orthopedic
    • 5.4.6. Gastroenterology
    • 5.4.7. Others
  • 5.5. End-user
    • 5.5.1. Hospitals
    • 5.5.2. Diagnostic and Imaging Centers
    • 5.5.3. Ambulatory Surgical Centers
    • 5.5.4. Others
  • 5.6. By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. South America
    • 5.6.5. Middle East & Africa
  • 5.7. Company Market Share (%), 2022

6. Global Magnetic Resonance Imaging Market Outlook, 2017-2031F

  • 6.1. North America*
    • 6.1.1. Field Strength
      • 6.1.1.1. Low
      • 6.1.1.2. Medium
      • 6.1.1.3. High
    • 6.1.2. Design
      • 6.1.2.1. Open MRI
      • 6.1.2.2. Traditional MRI
      • 6.1.2.3. Wide Bore MRI
    • 6.1.3. Application
      • 6.1.3.1. Neurology
      • 6.1.3.2. Cardiology
      • 6.1.3.3. Musculoskeletal
      • 6.1.3.4. Orthopedic
      • 6.1.3.5. Gastroenterology
      • 6.1.3.6. Others
    • 6.1.4. End-user
      • 6.1.4.1. Hospitals
      • 6.1.4.2. Diagnostic and Imaging Centers
      • 6.1.4.3. Ambulatory Surgical Centers
      • 6.1.4.4. Others
  • 6.2. Canada
  • 6.3. Mexico

All segments will be provided for all regions and countries covered

  • 6.4. Europe
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. Italy
    • 6.4.4. United Kingdom
    • 6.4.5. Russia
    • 6.4.6. Netherlands
    • 6.4.7. Spain
    • 6.4.8. Turkey
    • 6.4.9. Poland
  • 6.5. Asia Pacific
    • 6.5.1. India
    • 6.5.2. China
    • 6.5.3. Japan
    • 6.5.4. Australia
    • 6.5.5. Vietnam
    • 6.5.6. South Korea
    • 6.5.7. Indonesia
    • 6.5.8. Philippines
  • 6.6. South America
    • 6.6.1. Brazil
    • 6.6.2. Argentina
  • 6.7. Middle East & Africa
    • 6.7.1. Saudi Arabia
    • 6.7.2. UAE
    • 6.7.3. South Africa

7. Market Mapping, 2023

  • 7.1. Field Strength
  • 7.2. Design
  • 7.3. Application
  • 7.4. End-user
  • 7.5. Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis - Volume and Value
  • 8.3. Supply/Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancement
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges, Restraints)

10. Regulatory Framework and Innovation

  • 10.1. Clinical Trials
  • 10.2. Patent Landscape
  • 10.3. Regulatory Approvals
  • 10.4. Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. GE Healthcare Technologies Inc.
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Canon Medical Systems Corporation
  • 14.3. Koninklijke Philips N.V
  • 14.4. Siemens Healthineers AG
  • 14.5. Hitachi Ltd
  • 14.6. Aurora Imaging Technologies Inc.
  • 14.7. Fujifilm Holdings Corporation
  • 14.8. Neusoft Medical Systems Co. Ltd
  • 14.9. Bruker Corporation
  • 14.10. Fonar Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer